Michael R. McMullen
Net Worth
Last updated:
What is Michael R. McMullen net worth?
The estimated net worth of Mr. Michael R. McMullen is at least $188,335,939 as of 8 Mar 2024. He owns shares worth $30,496,890 as insider, has earned $119,119,049 from insider trading and has received compensation worth at least $38,720,000 in Agilent Technologies, Inc..
What is the salary of Michael R. McMullen?
Mr. Michael R. McMullen salary is $2,420,000 per year as Chief Executive Officer, Pres & Director in Agilent Technologies, Inc..
How old is Michael R. McMullen?
Mr. Michael R. McMullen is 64 years old, born in 1961.
What stocks does Michael R. McMullen currently own?
As insider, Mr. Michael R. McMullen owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | Chief Executive Officer, Pres & Director | 253,908 | $120.11 | $30,496,890 |
What does Agilent Technologies, Inc. do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Michael R. McMullen insider trading
Agilent Technologies, Inc.
Mr. Michael R. McMullen has made 57 insider trades between 2009-2024, according to the Form 4 filled with the SEC. Most recently he sold 52,297 units of A stock worth $7,844,550 on 8 Mar 2024.
The largest trade he's ever made was exercising 128,726 units of A stock on 22 Nov 2022. As of 8 Mar 2024 he still owns at least 253,908 units of A stock.